From April 1, 2023 to June 1, 2023, the company has repurchased 1,266,500 shares, representing 0.14% for CNY 38.99 million. With this, the company has completed the repurchase of 2,871,000 shares, representing 0.33% for CNY 99.99 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.57 CNY | +0.21% | -1.35% | -39.82% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.82% | 1.81B | |
+48.65% | 779B | |
+41.38% | 631B | |
-6.82% | 354B | |
+19.86% | 333B | |
+10.11% | 301B | |
+16.81% | 249B | |
-1.76% | 216B | |
+11.04% | 214B | |
+4.69% | 163B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.